Your browser is no longer supported. Please, upgrade your browser.
Settings
PTX Pernix Therapeutics Holdings, Inc. daily Stock Chart
PTX [NASD]
Pernix Therapeutics Holdings, Inc.
Index- P/E- EPS (ttm)-20.81 Insider Own2.00% Shs Outstand10.27M Perf Week6.61%
Market Cap38.10M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.08M Perf Month-6.55%
Income-169.60M PEG- EPS next Q- Inst Own25.80% Short Float16.22% Perf Quarter34.42%
Sales140.90M P/S0.27 EPS this Y22.10% Inst Trans- Short Ratio2.41 Perf Half Y11.75%
Book/sh-11.80 P/B- EPS next Y- ROA-44.10% Target Price30.00 Perf Year311.86%
Cash/sh3.54 P/C1.05 EPS next 5Y4.00% ROE467.10% 52W Range0.39 - 4.80 Perf YTD91.24%
Dividend- P/FCF- EPS past 5Y-52.90% ROI-75.20% 52W High-22.71% Beta1.91
Dividend %- Quick Ratio0.90 Sales past 5Y18.40% Gross Margin69.20% 52W Low851.04% ATR0.34
Employees185 Current Ratio1.00 Sales Q/Q-34.90% Oper. Margin-99.60% RSI (14)55.83 Volatility12.26% 8.74%
OptionableYes Debt/Eq- EPS Q/Q33.30% Profit Margin- Rel Volume10.30 Prev Close3.30
ShortableYes LT Debt/Eq- EarningsMar 28 AMC Payout- Avg Volume610.28K Price3.71
Recom3.00 SMA201.83% SMA508.18% SMA20061.11% Volume6,283,608 Change12.42%
Aug-12-16Downgrade Brean Capital Buy → Hold
Mar-11-16Downgrade Needham Buy → Hold
Mar-08-16Reiterated Needham Strong Buy $10 → $8
Sep-09-15Resumed JMP Securities Mkt Outperform
Aug-07-15Reiterated Needham Strong Buy $12 → $10
Aug-07-15Reiterated Brean Capital Buy $17 → $14
Jun-29-15Initiated Brean Capital Buy $17
Apr-28-15Reiterated Needham Strong Buy $16 → $12
Apr-22-15Initiated Piper Jaffray Overweight $14
Mar-26-15Initiated Oppenheimer Outperform $15
Feb-26-15Reiterated Needham Strong Buy $12 → $16
Nov-11-14Reiterated Needham Strong Buy $10 → $12
May-27-14Upgrade Aegis Capital Hold → Buy
May-15-14Upgrade Needham Buy → Strong Buy $6.30 → $10
Nov-13-13Reiterated Needham Buy $6 → $5
Oct-21-13Downgrade Aegis Capital Buy → Hold $3
Jul-26-13Downgrade Cantor Fitzgerald Hold → Sell $3 → $2.50
May-15-13Reiterated Cantor Fitzgerald Hold $7 → $3
May-14-13Reiterated Needham Buy $8 → $6
Mar-19-13Reiterated Needham Buy $11 → $8
Apr-19-17 02:32PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 19, 2017 Capital Cube
Apr-18-17 04:00PM  Platinex Inc.-Proposed Private Placement Marketwired
Apr-07-17 05:19PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 7, 2017 Capital Cube +5.37%
Apr-05-17 08:41AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017 Capital Cube -6.52%
08:41AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
Apr-01-17 01:04PM  PERNIX THERAPEUTICS HOLDINGS, INC. Financials
Mar-30-17 09:30AM  Today's Research Reports on Biotech Stocks to Watch: Catalyst Biosciences and Pernix Therapeutics Accesswire
Mar-29-17 10:10AM  Tuesdays Top Biopharma Movers -13.05%
Mar-28-17 11:07PM  Edited Transcript of PTX earnings conference call or presentation 28-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
11:07PM  Edited Transcript of PTX earnings conference call or presentation 28-Mar-17 8:30pm GMT
04:39PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-K, Annual Report
04:01PM  Pernix Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Mar-23-17 04:44PM  Pernix: An Investor's Rationale to Staying Long GuruFocus.com
04:44PM  Pernix: An Investor's Rationale to Staying Long
Mar-16-17 12:14AM  Webcast-Q4 Earnings Call for Pernix Therapeutics Holdings, Inc. at Company Spotlight
Mar-15-17 04:01PM  Pernix Therapeutics to Report Fourth Quarter and Year-End 2016 Financial Results on Tuesday, March 28 GlobeNewswire
Feb-23-17 09:30AM  Biotech's Rise Shows No Sign of Slowing Dow in 2017: Today's Reports on Pernix Therapeutics and Brainstorm Cell Therapeutics Accesswire +19.70%
08:00AM  Pernix Therapeutics Prevails in Zohydro® ER ANDA Litigation GlobeNewswire
Feb-03-17 08:00AM  Pernix Therapeutics Provides Update on Arbitration GlobeNewswire -18.12%
Jan-20-17 01:51PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 20, 2017
Jan-06-17 04:01PM  Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer GlobeNewswire +28.65%
12:05PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 6, 2017
Jan-05-17 09:55AM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q3, 2016 By the Numbers : January 5, 2017
Dec-07-16 08:15AM  Blog Coverage Teva Reports Positive Outcome for the European Label for COPAXONE®; Replaces Generics Head Accesswire
Nov-29-16 04:06PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-22-16 06:36AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement
06:30AM  Pernix Therapeutics Appoints New Board Member GlobeNewswire
Nov-10-16 04:46PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Nov-07-16 05:09PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement +7.24%
04:01PM  Pernix Therapeutics Appoints Two Board Members GlobeNewswire
Nov-01-16 02:47PM  Drug Makers Stocks Under Scanner -- Pernix Therapeutics, Novo Nordisk, Synergy Pharma, and Apricus Biosciences PR Newswire
Oct-31-16 04:30PM  Pernix Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016 GlobeNewswire
12:31AM  Drugmakers Turn Cheap Generics Into Expensive Pills at The Wall Street Journal
Oct-30-16 01:42PM  Drugmakers Turn Cheap Generics Into Expensive Pills at The Wall Street Journal
Oct-24-16 12:30PM  Edited Transcript of PTX earnings conference call or presentation 11-Aug-16 8:30pm GMT
Oct-14-16 11:08AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : October 14, 2016 +929.52%
07:03AM  Splits Calendar: Pernix Therapeutics splits before market open today (1:10 ratio)
Oct-13-16 08:57AM  Pernix Therapeutics Announces Reverse Stock Split and Corporate Governance Enhancements GlobeNewswire -25.81%
08:56AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendment
Sep-28-16 04:01PM  Pernix Therapeutics Announces Distribution of TREXIMET® 10/60 mg (sumatriptan 10mg and naproxen sodium 60 mg) Dose For Use in Pediatric Patients GlobeNewswire
Sep-21-16 10:55AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : September 21, 2016
Sep-16-16 07:00AM  Marsha Stanton, Ph.D., RN, Pernix Therapeutics Executive Director of Medical and Government Affairs, Awarded Prestigious Pain Management Advocacy Award from the American Society for Pain Management Nursing® GlobeNewswire
Sep-14-16 07:00AM  Pernix Therapeutics Announces the Issuance of Two New Orange Book Listed Patents for Zohydro® ER with BeadTek GlobeNewswire
Sep-09-16 08:00AM  Pernix Therapeutics Announces Significant Presence at PAINWeek 2016 GlobeNewswire
Sep-07-16 11:03AM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : September 7, 2016
Aug-12-16 06:14AM  Pernix Therapeutics downgraded by Brean Capital -5.93%
Aug-11-16 04:49PM  Pernix Therapeutics reports 2Q loss
04:40PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Pernix Therapeutics Reports Second Quarter 2016 Financial Results and Business Update GlobeNewswire
07:07AM  Q2 2016 Pernix Therapeutics Holdings Inc Earnings Release - After Market Close
Aug-04-16 03:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 4, 2016 +15.35%
06:30AM  Pernix Therapeutics to Report Second Quarter 2016 Financial Results on August 11, 2016 GlobeNewswire
Jul-26-16 05:41PM  Pernix Therapeutics Announces Reorganization of Senior Management Team GlobeNewswire
Jul-18-16 02:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : July 18, 2016
Jul-08-16 12:06PM  These 5 Stocks Are Breaking Out +11.36%
Jul-07-16 04:53PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +11.86%
09:21AM  Todays Hot Stocks: Buckle, Boeing, Ford, and More at Insider Monkey
06:30AM  Pernix Therapeutics Announces Restructuring of Sales Force and Operations GlobeNewswire
Jun-22-16 10:31AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
08:52AM  Research Report Initiated on Select Healthcare Equities
Jun-21-16 01:12PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 21, 2016
Jun-16-16 08:00AM  Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study GlobeNewswire +12.52%
Jun-09-16 11:06AM  5 Stocks Under $10 Set to Soar +9.54%
Jun-07-16 05:45PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 7, 2016
04:16PM  Steven Cohen Adds to Stake in Pernix Therapeutics
May-31-16 08:34AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-26-16 07:37AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -11.37%
May-25-16 08:00AM  Pernix Therapeutics Announces the Issuance of Three New Orange Book Patents for Zohydro® ER with BeadTek GlobeNewswire
May-19-16 04:01PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
May-18-16 10:47PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 19, 2016
May-17-16 03:51PM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q1, 2016 By the Numbers -5.82%
May-11-16 01:51PM  Pernix Therapeutics Names John Sedor As Chairman and Interim CEO In Place Of Dough Drysdale -17.04%
08:02AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing
08:00AM  Pernix Therapeutics Announces CEO Transition GlobeNewswire
May-09-16 08:00AM  Pernix Therapeutics Overcomes Challenge to Treximet® 183 Patent GlobeNewswire
May-05-16 01:40PM  Is Pernix Therapeutics in a Race to Zero? at 24/7 Wall St. -45.80%
09:19AM  Pernix Therapeutics reports 1Q loss AP
08:46AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
08:00AM  Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update GlobeNewswire
07:07AM  Q1 2016 Pernix Therapeutics Holdings Inc Earnings Release - Before Market Open CCBN
May-03-16 02:32PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 3, 2016 at Capital Cube +11.72%
May-02-16 03:20PM  Dollar in focus as stocks rebound to start week Yahoo Finance +31.26%
12:40PM  This Pharma Company is Soaring After Steve Cohen Boosts Stake, GrubHub Inc. (GRUB) Has a Bullish New Investor, Plus 2 Other Moves at Insider Monkey
Apr-28-16 08:30AM  Pernix Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016 GlobeNewswire
07:39AM  Government Spending On Opioid Epidemic Creates Surprising Beneficiary Company Spotlight
Apr-14-16 02:52PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 14, 2016
Apr-05-16 05:00PM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
04:01PM  Pernix Therapeutics to Present at Needham & Companys 15th Annual Healthcare Conference GlobeNewswire
Mar-24-16 05:50PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : March 24, 2016 -12.88%
Mar-23-16 08:38AM  6 Biotech Stocks Under $10 to Trade for Big Breakouts at TheStreet +20.00%
Mar-14-16 04:06PM  ETFs with exposure to Pernix Therapeutics Holdings, Inc. : March 14, 2016 -9.06%
12:22PM  Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-10-16 09:45AM  PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-K, Annual Report -19.30%
09:11AM  Pernix Therapeutics reports 4Q loss
08:00AM  Pernix Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update GlobeNewswire
07:07AM  Q4 2015 Pernix Therapeutics Holdings Inc Earnings Release - Before Market Open
Mar-02-16 08:30AM  Pernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek CII GlobeNewswire
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products. The company's products comprise Treximet, a medication indicated for the acute treatment of migraine attacks in adults; Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a medication indicated for the treatment of insomnia characterized by difficulty with sleep maintenance; and Khedezla, a prescription medication for major depressive disorder. Its products also include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro and Rezira for the relief of cough and nasal congestion; Vituz, a hydrocodone bitartrate and chlorpheniramine maleate combination oral solution for the treatment of cough and allergies associated with the common cold; and OMECLAMOX-PAK, a gastroenterology product. The company sells its products through its sales force and third-party sales organizations, as well as through its subsidiaries. It serves drug wholesalers, retail drug stores, mass merchandisers, and grocery store pharmacies in the United States. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.